Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6072213 | 0.93 | TDP1 (0.32) | IRAK4 | |
| SCHEMBL6071815 | 0.91 | SMN1; SMN2 (0.34) | IDO1IRAK4 | |
| SCHEMBL6072284 | 0.90 | IDO1 (0.33) | IDO1IRAK4 | |
| SCHEMBL6072931 | 0.89 | HDAC1 (0.39) | — | |
| SCHEMBL6072762 | 0.88 | IDO1 (0.32) | IDO1 | |
| SCHEMBL6072217 | 0.87 | CREBBP (0.38) | — | |
| SCHEMBL6072777 | 0.87 | AKR1C3 (0.35) | IDO1 | |
| SCHEMBL6072196 | 0.87 | HSD17B10 (0.36) | IDO1 | |
| SCHEMBL6072322 | 0.86 | PDE10A (0.32) | IDO1 | |
| SCHEMBL6072191 | 0.86 | ACLY (0.38) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060106048-A1 | Furoisoquinoline derivative and use thereof | PASCALI, PETROS P. (CY) | 2006-05-18 | — | — | US | disclosed |
| EP-1541576-A1 | FUROISOQUINOLINE DERIVATIVE AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2005-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106048-A1 | Furoisoquinoline derivative and use thereof | PDE3B, PDE2A, PDE3A | IDO1 1813/4885IRAK4 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.